Immune hemolytic anemia due to diclofenac

Immunohematology

Volumn 13, Issue 1, 1997, Pages 9-11

  Laidlaw, S T ^a   Stamps, R ^b   Booker, D J ^b   Brown, M J ^a   Sokol, R J ^b  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; FOLIC ACID; IMMUNOGLOBULIN G; PREDNISOLONE;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; CASE REPORT; CONTROLLED STUDY; COOMBS TEST; DRUG INDUCED DISEASE; GOUT; HEMOGLOBINURIA; HUMAN; JAUNDICE; MALE; PRIORITY JOURNAL;

EID: 0031029051     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Garratty G. Drug-induced immune hemolytic anemia. In: Garratty G, ed. Immunobiology of transfusion medicine. New York. Marcel Dekker. 1993:523-51.
2. Petz LD. Drug-induced immune hemolytic anemia. In: Nance SJ, ed. Immune destruction of red blood cells. Arlington, VA: American Association of Blood Banks, 1989:53-75.
3. Mueller-Eckhardt C, Salama A. Drug-induced immune cytope-nias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus Med Rev 1990;IV:69-77.
4. Petz LD. Drug-induced autoimmune hemolytic anemia. Transfus Med Rev 1993;VII:242-54.
5. Sokol RJ, Booker DJ, Stamps R. Investigation of patients with autoimmune hemolytic anemia and provision of blood for transfusion. J Clin Pathol 1995;48:602-10.
6. Salama A, Mueller-Eckhardt C. The role of metabolite-specific antibodies in nomifensine-dependent immune hemolytic anemia. N Engl J Med 1985;313:469-74.
7. Petz LD, Branch DR. Drug-induced immune hemolytic anemia. In: Chaplin H, ed. Immune hemolytic anemias. New York: Churchill Livingstone, 1985:47-94.
8. kramer MR, Levene C, Hershko C. Severe reversible autoimmune haemolytic anaemia and thrombocytopenia associated with diclofenac therapy. Scand J Haematol 1986;36:118-20.
9. Lopez A, Linares M, Sánchez H, Blanquer A. Autoimmune hemolytic anemia induced by diclofenac. Ann Pharmacother 1995:29:787.
10. Heuft HG, Postels H, Hoppe L, et al. Eine tödlich verlaufene immunhämolytische Anämie nach Applikation von Diclofenac. Beitr Infusionsther 1990;26:412-4.
11. Johnson ST, Weitekamp LA, Wilkins JL, et al. Diclofenac-dependent antibody with relative e specificity causing hemolytic anemia and emphasizing the need for metabolite testing. Transfusion 1993;33(Suppl):63S.
12. Salama A, Götische B, Mueller-Eckhardt C. Autoantibodies and drugs or metabolite-dependent antibodies in patients with diclofenac-induced immune haemolysis. Br J Haematol 1991;77:546-9.